Navigation Links
Cholesterol-lowering drugs may reduce mortality for influenza patients
Date:12/16/2011

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by the Journal of Infectious Diseases.

It is the first published observational study to evaluate the relationship between statin use and mortality in hospitalized patients with laboratory-confirmed influenza virus infection, according to Vanderbilt's William Schaffner, M.D., professor and chair of Preventive Medicine.

"We may be able to combine statins with antiviral drugs to provide better treatment for patients seriously ill with influenza," said Schaffner, who co-authored the study led by Meredith Vandermeer, MPH, of the Oregon Public Health Division.

Researchers studied adults who were hospitalized with laboratory-confirmed influenza from 2007-2008 to evaluate the association between patients who were prescribed statins and influenza-related deaths.

Among 3,043 hospitalized patients with laboratory-confirmed influenza, 33 percent were given statin medications prior to or during hospitalization. After adjusting for various factors, researchers found that patients not receiving statins were almost twice as likely to die from influenza as those who received the medication.

Schaffner stressed that receiving the influenza vaccine each year is still the best defense against influenza. The Centers for Disease Control and Prevention (CDC) estimates that between 5 percent and 20 percent of U.S. residents get the flu each year, and more than 20,000 persons are hospitalized for flu-related complications.


'/>"/>
Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert  

Page: 1

Related medicine news :

1. Cholesterol-lowering drug shrinks enlarged prostates in hamster model
2. Cholesterol-lowering drugs may help prevent recurrent strokes in younger people
3. Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds
4. Cholesterol-lowering medication accelerates depletion of plaque in arteries
5. The private sale of drugs in public hospitals
6. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
7. Adapting to clogged airways makes common pathogen resist powerful drugs
8. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
9. Drugs That Shift Cells Energy Find New Purpose
10. FDA Tightens Controls on Anemia Drugs
11. FDA Issues Warning on Key Asthma Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol-lowering drugs may reduce mortality for influenza patients
(Date:8/16/2017)... ... August 16, 2017 , ... Richard Strawn’s new book ... time of a cancer diagnosis, surgery and recovery, the Psalms provided encouragement and ... ways God shows love to those who are sick., Surgical Psalms contains 36 ...
(Date:8/16/2017)... ... 16, 2017 , ... The Visiting Nurse Association (VNA) ... train as hospice volunteers. Volunteers provide much needed joy, support and assistance to ... agency has trained volunteers to be vital members of the interdisciplinary hospice care ...
(Date:8/16/2017)... ... , ... Rollon Skin Care Ltd., one of ... the launch of two new skincare products, Prache Antiaging Cream and Prache Antiaging ... surgery or in-patient cosmetic dermatological procedures. , “Prache Antiaging Cream and Prache Antiaging ...
(Date:8/16/2017)... ... ... “Faith, Through The Eyes of A Child” is the creation of published author, Pauline DiBenedetto. ... at her. Since she was in such great pain, my mother thought that her time ... well. It wasn’t until I was about eight years old, when I had a vision ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... August 14 and host a conference call at 9:00am ... operating and financial results and its strategy and outlook ... hosted by Erez Raphael , Chief Executive Officer, ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... , Aug. 7, 2017 Insightin Health, ... acquisition, retention, and engagement, announced the selection of ... and Product Development, effective as of February 2017. In ... technology implementation strategy for our clients. Wood brings ... in consulting and business analytics within the healthcare ...
Breaking Medicine Technology: